Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen
Susan L Baldwin, Will Roeffen, Susheel K Singh, Regis W Tiendrebeogo, Michael Christiansen, Elyse Beebe, Darrick Carter, Christopher B Fox, Randall F Howard, Steven G Reed, Robert Sauerwein, Michael Theisen
Dive into the research topics of 'Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2.6C multi-stage vaccine antigen'. Together they form a unique fingerprint.